Milestone Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Milestone Pharmaceuticals

10/11/2022 14:32

* Milestone Pharmaceuticals Inc  MIST.OQ  reported a
quarterly
adjusted loss of 34 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 41 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Milestone Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 34 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Milestone Pharmaceuticals Inc shares had fallen by 55.5%
this
quarter and lost 37.6% so far this year.
    * The company reported a quarterly loss of $14.56 million.
    * Wall Street's median 12-month price target for Milestone
Pharmaceuticals Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.41          -0.34          Beat
 Jun. 30 2022      -0.36          -0.39          Missed
 Mar. 31 2022      -0.39          -0.33          Beat
 Dec. 31 2021      -0.36          -0.40          Missed